<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Cystic medial degeneration (CMD) is a histologic abnormality that is common in <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic diseases</z:e> such as <z:mp ids='MP_0010574'>aortic dilation</z:mp>, <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, or dissection </plain></SENT>
<SENT sid="1" pm="."><plain>Although little is known about the mechanism underlying CMD, we have previously demonstrated that <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> signaling via <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 2 receptor (AT2R) plays a central role in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of vascular smooth muscle cells (VSMCs) occurring in CMD associated with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study is to elucidate the role of <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> signaling in THE pathogenesis of <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic diseases</z:e> associated with CMD </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: We investigated the effects of <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitor</z:chebi> (ACEI), temocapril (n = 15), <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> receptor type-1 (AT1R) blocker, CS-866 (n = 15), and vehicle control (n = 17) on 0.25% <z:chebi fb="0" ids="27413">beta-aminopropionitrile</z:chebi> monofumarate (<z:chebi fb="0" ids="27413">BAPN</z:chebi>)-induced <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> and histopathologic findings in a rat model </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Temocapril significantly prevented <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> (P &lt;.05), CMD (P &lt;.01), and VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (P &lt;.01) compared with vehicle control in <z:chebi fb="0" ids="27413">BAPN</z:chebi>-fed rats </plain></SENT>
<SENT sid="5" pm="."><plain>However, CS-866 did not show any preventive effect </plain></SENT>
<SENT sid="6" pm="."><plain>Reversed transcriptase-polymerase chain reaction demonstrated that expression of both AT1R and AT2R was detected in control rat aortas, and that AT2R expression was significantly upregulated in the aortas of <z:chebi fb="0" ids="27413">BAPN</z:chebi>-fed rats (P &lt;.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Blood pressure was significantly and equally lowered in both temocapril and CS-866 groups compared with control </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Differential expression of <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> receptors and AT2R signaling are involved in the pathogenesis of CMD and <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> in <z:chebi fb="0" ids="27413">BAPN</z:chebi>-fed rats </plain></SENT>
<SENT sid="9" pm="."><plain>ACEIs might be of clinical value for the prevention and treatment of <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic diseases</z:e> related to CMD </plain></SENT>
</text></document>